🎉 Congratulations to the Lightning Talk Speakers of FCS 2025! We’re proud to celebrate ten researchers whose work advances the understanding and treatment of cancer. Join us in applauding their achievements at #FCS2025, 5–7 November in Singapore!

We’re live at the 📌 NUS University Cultural Centre for the Frontiers in Cancer Science Conference 2025! 🌟 Come by to register on-site or via the link: csi.nus.edu.sg/fcs/#registr... Keep updated on the conference activities on CSI Singapore's IG Stories.

🎉 Congratulations to our FCS 2025 Outstanding Abstract Travel Award Winners! We’re proud to celebrate ten exceptional early-career researchers whose work advances the understanding and treatment of cancer. Join us in applauding their achievements and welcoming them to #FCS2025 csi.nus.edu.sg/fcs/

Last week, CSI Singapore hosted Dr. Simon Boulton from @crick.ac.uk. He spoke on the topic “Exploiting the ‘End Replication Problem’ in Cancer”. #cancerresearch #oncology #cancerscience #oncologyresearch #telomeres

An afternoon of learning, care, and connection 💬 Dr. Patrick Tan shared practical health and first aid tips to help everyone stay safe and look out for one another at work. Dr. Yong Wai Khang followed with “Feeling Down? Who Can You Talk To?” — a gentle reminder that support is always close by.

Congratulations to Prof. Yang Zhang who has received a grant under the RIE 2025 Human Health & Potential Industry Alignment Fund Pre-Positioning for project titled “BioStream: An AI-Enabled Innovative Platform to Streamline the Development of Next Generation Biologics.” #AIinScience #AIplatform

CSI Singapore would like to welcome onboard Dr. Peter Yeow to our CSI community 👏 His research focus is targeting cancer cell division and TRIM E3 ligases. Read more about him: csi.nus.edu.sg/researcher/p... #csisingapore #cancerawareness #cancerresearch #cancerresearchinstitute #cancereducation

The CSI Singapore – @kyotouniversity.bsky.social Joint Symposium 2025 will be taking place from 24 to 26 Nov at NUS. The symposium will bring together leading researchers from both institutions to exchange insights & foster collaborations in cancer science & biomedical research. 📌Save the date!

🎉We are proud to announce that several of our researchers have been featured in the Top 2% Most Cited Scientists list, a prestigious global database compiled by Stanford University and published by Elsevier. 👏 We celebrate your dedication, innovation, and excellence! #cancerresearch

Today is World Cancer Research Day — a reminder of the importance of research in shaping better treatments and outcomes. The Straits Times has featured CSI PI, Prof. Chng Wee Joo, for his work in blood cancers like multiple myeloma. #WorldCancerResearchDay #CancerResearch #HopeThroughScience

📢 Thank you to everyone who joined us at the CSI Core Facilities Roadshow last Wednesday! Our facilities span across: 🔬 Flow Cytometry 🧬 Genome Engineering 💡 Quantitative Proteomics 🌐 Spatial Biology 📊 Genomics Data Analytics #CoreFacilities #ResearchSupport #BiomedicalResearch #CancerResearch

Interested in Pursuing a PhD in Cancer Biology? Join us for the CSI Graduate Program Virtual Sharing Session! Discover opportunities & scholarship available for successful applicants. Hear from current scholars as they share their research experiences. #CancerResearch #CancerBiology #PhDProgram

Last week, CSI Singapore hosted Dr. Michel Steinmetz from @psich.bsky.social. He spoke on the topic “Microtubule-mediated Signal Transduction and Interactions with Anticancer Drugs”. #CancerResearch #Oncology #CancerScience #OncologyResearch #Microtubules #SignalTransduction #CancerBiology

🚀 Discover how CSI Core Facilities can power your research. Join us and see the difference! #Research #Science #BiomedicalResearch #CancerResearch

NUS-led study, among the largest ex-vivo drug testing efforts, confirms AI-guided personalized medicine for lymphoma. QPOP accurately predicted treatment response in ~75% of 117 patients, showing its potential to tailor therapies. #CancerResearch #AI #PrecisionMedicine ascopubs.org/doi/10.1200/...

A huge THANK YOU to everyone for an amazing afternoon at Timezone for the annual CSI Staff Party! 🥳 Your energy, laughter, and team spirit lit up the arcade and turned it into a celebration to remember. Check out CSI Singapore's Facebook page for the photos and videos under 'Albums' 🤩

🚨 Program update! Frontiers in Cancer Science 2025 is just 2 months away — Nov 5–7 at NUS, Singapore. 🎤 Global experts 🧬 Cutting-edge sessions 🔗 Learn more and register (if you haven’t already): csi.nus.edu.sg/fcs Refer to our website for the full program drop!

Last week, CSI Singapore hosted Dr. Makoto Hayashi, from Kyoto University / @ifomresearch.bsky.social. He spoke on the topic “The Mechanism of Mitotic Arrest Dependent Telomere Deprotection”.

Today, CSI Singapore hosted Dr. Alexia-Ileana Zaromytidou, Chief Editor at Nature Cancer (@nature.com @natureportfolio.nature.com) She spoke on the editorial and publishing processes at Nature Cancer and the Nature journals.

We’re proud to share that CSI Singapore Research Fellow, Dr. Jun Liu has been awarded the NMRC Open Fund – Young Individual Research Grant for his project titled “Genome-Wide Antibody-Antigen Interaction Prediction Through Large Language Models.” #CSISingapore #NMRC #AIinScience #CancerResearch

Ready to take your research to the next level? Apply now for CSI Postdoctoral Fellowship and unlock new opportunities for growth and discovery! #csisingapore #cancerresearch #cancerbiology #cancerbio #oncology #postdoc

The Diana Koh Breakthroughs in Cancer Learning Series 2025 featured talks by Prof. Goh Boon Cher and Dr. @denniskappei.bsky.social, who made cancer science accessible. Congrats to our Young Innovator Prize & Grant winners! #CancerResearch #ScienceOutreach #DianaKohSeries #CSISingapore

#FCS2025 is fast approaching! 👇Browse through the stellar speaker lineup for this year and take this opportunity to submit your abstract as deadline has been extended till 28 July! ⏳ 🔗https://csi.nus.edu.sg/fcs

A @csisingapore.bsky.social team showed D-I-Tasser can outperform AlphaFold2/3, elevating high-accuracy protein structure & function predictions. We wonder if this moves us closer to resolving protein–protein complex structure prediction? @natbiotech.nature.com www.nature.com/articles/s41...

🚨 Deadline extended: Submit your #FCS2025 abstract by 28 July! Present your research, meet top cancer scientists, and enjoy early-bird rates. 🏆 Travel award for top oral abstracts 🎖Top poster abstracts eligible for travel awards for #AACR2026. More info & registration 👉 csi.nus.edu.sg/fcs

Yesterday, CSI had the pleasure of hosting Professor Sarah-Jane Dawson ( @petermaccc.bsky.social, University of Melbourne) for a seminar on “Circulating Tumour DNA: Going Beyond the Cancer Genome.” Thank you to all who joined us!

Last week, CSI Singapore together with NUS Centre for Cancer Research and A*STAR Institute of Molecular and Cell Biology, hosted a symposium with speaker - Prof. Patrick Chinnery, from the UK Medical Research Council. He spoke on the topic “An Evolving Symbiosis: Mitochondria in Health and Disease”.

CSI Singapore joins hands with Dunman Secondary, SG Code Campus, Google Cloud, and IMDA in the *Google AI Accelerator* programme. We’re preparing future innovators to tackle healthcare challenges with real-world biomedical data and AI tools.

Exciting news from our Director, Professor Ashok Venkitaraman. His lab's groundbreaking findings published in Molecular cell, sheds new light into how BRCA2 acts to suppress carcinogenesis, with implications for cancer prevention and therapy. 🔗 Read the full study: www.cell.com/molecular-ce...

Targeting transcription factors through an IMiD independent #ZincFingerDomain By B. H. Liu, M. Liu, D. G. Tenen, L. Chai & colleagues @csisingapore.bsky.social 🗞️ doi.org/10.1038/s443...

2 days left to the opening of registration and abstract submission for #FCS2025 on 1 May! ⏰

The newly-inducted 2025 class of Fellows of the AACR Academy are introduced to the #AACR25 delegates at the AACR Annual Meeting Opening Ceremony.

Huge congratulations to our Director, Prof. Ashok Venkitaraman, on his induction to the AACR Academy at #AACR25! Honored for pioneering work on BRCA2, cancer mechanisms, and advancing drug discovery. #CancerResearch #AACR

We’re excited to be at #AACR25! Join us at the Career Fair today, and visit our exhibit booth (3707) starting tomorrow. Come by and say hello!

THE @theaacr.bsky.social AACR ANNUAL MEETING 2025 is one week away! Visit us at the AACR Career Fair on 26 April 2025, at booth CF23 We will also be at the AACR Exhibit Hall Booth # 3707 SEE YOU!!

We would like to congratulate our Director, Professor Ashok Venkitaraman, for being appointed as Chief Scientist of the Biomedical Research Council (BMRC) at the Agency for Science, Technology and Research (A*STAR). @astarsg.bsky.social

Congratulations to Assistant Professor Anand JEYASEKHARAN for being accepted into @theaacr.bsky.social Annual Meeting 2025 's NEXTGEN STARS Program.

Ready to take your research to the next level? Apply now for CSI Postdoctoral Fellowship and unlock new opportunities for growth and discovery! #csisingapore #cancerresearch #cancerbiology #cancerbio #oncology #postdoc

Gear up for Singapore’s esteemed cancer conference, Frontiers in Cancer Science 2025!! #FCS2025 will be taking place from 5 to 7 Nov 2025. Abstract submission and registration will OPEN ON 1 MAY 2025. Follow us for more updates. Learn more: csi.nus.edu.sg/fcs/

Congratulations to our Director Professor Ashok Venkitaraman for the launch of the new S$130 million national research initiative, known as the National Initiative for RNA Biology and Its Applications (NIRBA). news.nus.edu.sg/new-national...

In this 'A Model for Life' interview, we discuss Ashok Venkitaraman's outstanding research journey, how this translates to tangible clinical outcomes and how these outcomes can be shared globally. @csisingapore.bsky.social doi.org/10.1242/dmm....

Warmest congratulations to Professor Ashok Venkitaraman, Director of CSI Singapore, who is among 33 distinguished scientists from around the world elected to the 2025 class of Fellows of the American Association for Cancer Research (AACR)! @theaacr.bsky.social news.nus.edu.sg/prof-ashok-v...

#RelayForLifeSG – we did it! 🎉 100km completed!!! 💪💪 Huge shoutout to all our amazing participants—your dedication and team spirit made this possible! With teamwork, anything is achievable! 🔥💜 #StrongerTogether #CancerResearch #cancersupport

Today, CSI Singapore hosted an in-person CSI Seminar Series with speaker - Prof. Andrew Hsieh, from Fred Hutch. He spoke on the topic “mRNA Translation in Cancer Etiology”. #csisingapore #cancerresearch #cancerresearchinstitute #mRNA #mRNATechnology

🌍 Happy International Women’s Day! 🌸 At CSI Singapore we’re proud to support our female research students who are pushing boundaries, driving innovation, and shaping the future of science and discovery. Let’s continue to inspire, break barriers, and make a lasting impact! 💪 #WomenInResearch #IWD2025

Today, CSI Singapore hosted an in-person CSI Distinguished Speakers' Series with speaker - Prof. Seishi Ogawa, from Kyoto University, Japan. He spoke on the topic "Distinct Roles of Wnt Pathway Mutations in Colorectal Cancer" @ashbi-kyotou.bsky.social

Yesterday, CSI Singapore hosted an in-person CSI Seminar Series with speaker - Prof. Yasuhiro Murakawa, from Kyoto University. He spoke on the topic “Harnessing Functional Genomics to Elucidate Cancer-specific RNAs and their Regulation”.

CSI Singapore would like to welcome onboard our new Principal Investigator, Dr. Yilong Zhou to our CSI community 👏 Read more about him: csi.nus.edu.sg/researcher/y... #csisingapore #cancerawareness #cancerresearch #cancerresearchinstitute #cancereducation

💡 Join us at the CSI Core Facilities Roadshow! 💡 This is the perfect opportunity to learn how the cutting-edge services provided by our core facilities can accelerate your projects. 📅 21st February, Friday, MD11, CRC Auditorium Foyer, 1130am - 230pm

Published in The Lancet Oncology, a Phase II clinical trial led by Professor Goh Boon Cher, a Senior Principal Investigator, at CSI Singapore found that one-third of NPC patients who previously did not respond to pembrolizumab alone showed clinical improvement after adding bevacizumab. Link in bio.